You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 5, May 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Myelin in Multiple Sclerosis

Composition of Myelin From Normal-Appearing White Matter

Kunihiko Suzuki, MD; Shigehiko Kamoshita, MD; Yoshikatsu Eto, MD; Wallace W. Tourtellotte, MD, PhD; Jacqueline O. Gonatas

Arch Neurol. 1973;28(5):293-297.


Abstract

Myelin was isolated from white matter of five normal control brains and from normalappearing white matter of five patients with multiple sclerosis. There was statistically significant reduction of 25% to 30% in yield of myelin from abnormal brains, due probably to inadvertent inclusion of small lesions. No abnormalities were found in distribution of major constituents—chloroform-methanol soluble and insoluble proteins and total lipid. Analysis of individual lipids, and fatty acid composition of sphingolipids likewise did not show any differences between control and multiple sclerosis myelin. Contrary to a previous report, myelin isolated from normal-appearing white matter of multiple sclerosis brains contained normal amounts of myelin basic protein. Chemical composition of the myelin sheath in normal-appearing white matter of multiple sclerosis patients is, therefore, completely normal, at least for analytical factors examined.



Author Affiliations

Philadelphia; Tokyo; Philadelphia; Los Angeles; Philadelphia

From the Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia (Drs. Suzuki and Eto, and Mrs. Gonatas); Department of Pediatrics, University of Tokyo, Faculty of Medicine (Dr. Kamoshita); and V. A. Wadsworth Hospital Center, and Department of Neurology, University of California School of Medicine, Los Angeles (Dr. Tourtellotte). Dr. Suzuki is now with the Saul R. Korey Department of Neurology, and Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, NY; and Dt. Eto is with the Department of Pediatrics, University of Bern, Switzerland.


Footnotes

Accepted for publication Dec 12, 1972.

Reprint requests to Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, 1410 Pelham Parkway South, Bronx, NY 10461 (Dr. Suzuki).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Podbielska and Hogan
Mult Scler 2009;15:1011-1029.
ABSTRACT  

Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis
Ge et al.
Am. J. Neuroradiol. 2003;24:1935-1940.
ABSTRACT | FULL TEXT  

Fatty Acid Composition of Lipids in Cerebral Myelin and Synaptosomes in Phenylketonuria and Down Syndrome
Johnson et al.
Arch Neurol 1977;34:288-294.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.